During the therapeutic cloning process, cloned blastocyst (fertilized embryos) is used to extract embryonic stem cells [1]. These stem cells show promise for the research of genetic illness since they are genetically identical to the donor organism.

Also, therapeutic cloning, despite ethical debates, holds great promise for the future of regenerative medicine by circumventing immunorejection. Therapeutic cloning is tied to ethical and moral debates regarding the destruction of remaining embryonic cells [2]. Cells that are genetically similar to a patient might be created using this method and these cells might be put into a patient without the complications of immunorejection. Both uses of therapeutic cloning remain a working progress and possibility of the future. 

 

    Kfoury, C. (2007) Therapeutic cloning: Promises and issues, McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students. McGill University. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323472/#:~:text=Therapeutic%20cloning%20is%20the%20transfer,genome%20as%20the%20nuclear%20donor. (Accessed: October 17, 2022).

‌

Liu, Y. et al. (2022) “The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: A systematic review and meta-analysis of randomized controlled clinical trials,” Stem Cell Research & Therapy, 13(1), pp. 1–16. Available at: https://doi.org/10.1186/s13287-022-02882-4. (Accessed 10 Oct 2022).

Xu, R. et al. (2022) “Ccr2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure,” Stem Cell Research & Therapy, 13(1), pp. 1–15. Available at: https://doi.org/10.1186/s13287-022-02729-y. (Accessed 10 Oct 2022).